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Abstract. We have directly measured the contribution 
of dystrophin to the cortical stiffness of living muscle 
cells and have demonstrated that lack of dystrophin 
causes a  substantial reduction in stiffness. The inferred 
molecular structure of dystrophin,  its preferential lo- 
calization underlying the cell surface, and the apparent 
fragility of muscle cells which lack this protein sug- 
gest that dystrophin stabilizes the sarcolemma and pro- 
tects the myofiber from disruption during contraction. 
Lacking dystrophin,  the muscle cells of persons with 
Duchenne muscular dystrophy (DMD) are abnormally 
vulnerable.  These facts suggest that muscle cells with 
dystrophin should be stiffer than  similar cells which 
lack this protein.  We have tested this hypothesis by 
measuring the local stiffness of the membrane skeleton 
of myotubes cultured from mdx mice and normal con- 
trois.  Like humans  with DMD mdx mice lack dystro- 
phin due to an x-linked mutation and provide a good 
model for the human disease.  Deformability was mea- 
sured as the resistance to identation of a small area of 
the cell surface (to a depth of 1 /~m) by a glass probe 
1 #m in radius.  The stiffness of the membrane skele- 
ton was evaluated as the increment of force (mdyne) 
per/~m of indentation.  Normal myotubes with an aver- 
age stiffness value of 1.23  +  0.04 (SE) mdyne//zm 
were about fourfold stiffer than myotubes cultured 
from mdx mice (0.34  5:0.014 mdyne/#m).  We 
verified by immunofluorescence that both normal and 
mdx myotubes, which were at a  similar developmental 
stage, expressed sarcomeric myosin, and that dystro- 
plain was detected, diffusely distributed,  only in nor- 
mal,  not in mdx myotubes. These results confirm that 
dystrophin and its associated proteins can reinforce the 
myotube membrane skeleton by increasing its stiffness 
and that dystrophin function and, therefore, the 
efficiency of therapeutic restoration of dystrophin can 
be assayed through  its mechanical effects on muscle 
cells. 
A  early  step  leading  to  the  pathology  of Ducherme 
muscular dystrophy (DMD) 1 is thought  to be the 
disruption  of muscle cells  deficient  in dystrophin 
(Mokri and Engel,  1975; Weller et al.,  1990). Dystrophin's 
inferred molecular structure and  cellular location suggest 
that it is an essential link in a chain of interactions which con- 
nects the actin cytoskeleton to the extraceUular matrix  (Er- 
vasti and Campbell, 1993a). These structures could stabilize 
the sarcolemma and protect it from disruption during muscle 
contraction (Zubrzycka-Gaarn et al., 1988). Hence, normal 
muscle ceils should be mechanically  stiffer than those which 
lack dystrophin.  We have tested and confirmed this hypothe- 
sis  using  quantitative  measurements  of the  local  surface 
deformability  of muscle  cells  in  culture.  In  addition  to 
verifying  a  proposed  mechanical  function  of dystrophin 
these measurements demonstrate the possibility of using me- 
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tein; DMD,  Duchenne muscular dystrophy. 
chanical measurements  to test the function of dystrophin re- 
stored to cells which originally  lack it and thereby to judge 
at the cellular  level the success of therapeutic  strategies  for 
restoration ofdystrophin. The measurements reported in this 
paper provide the basis for an assay of dystrophin  function 
in living muscle cells. 
Dystrophin,  a  large  (427  kD) cytoskeletal protein,  has 
four distinct  domains.  From the amino terminus  these in- 
clude an actin-binding  domain analogous  to that in ot-acti- 
nin,  a  large  rod-like  domain  of 24-spectrin-like  repeats, 
a domain similar to a region ofDictyostelium c~-actinin with 
two  Ca~÷-binding sites  (which  may  be  nonfunctional  in 
skeletal muscle dystrophin),  and, finally, a carboxyl terminal 
domain presumed to interact  with the plasma membrane 
(Koenig et al., 1988; Ervasti and Campbell, 1993a). Dystro- 
phin seems to interact with a group of dystrophin associated 
proteins at the plasma membrane, most directly with a 59- 
kD protein on the cytoplasmic surface of the sarcolemma, 
which in turn associates with a complex of four transmem- 
brahe glycoproteins  (Ervasti and Campbell, 1993b). Bound 
to these at  the extracellular  surface,  a  large  heavily  gly- 
cosylated protein,  ot-dystroglycan, binds to laminin (Ervasti 
and Campbell,  1993c).  Hence,  dystrophin  links  the actin 
cytoskeleton to the extracellular  matrix  via a complex of 
membrane-associated proteins. 
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directly test the proposed mechanical function of dystrophin. 
We have compared the deformabilities of  myotubes in culture 
derived from both normal and mdx mice, which lack dystro- 
phin and provide a suitable model for DMD (Stedman et al., 
1991; Partridge, 1991). Deformability was measured as local 
resistance to cellular indentation (Petersen et al.,  1982). 
Materials and Methods 
Myotube Culture 
Muscle myotubes were cultured  from primary satellite  cells  of normal 
(C57BL/10ScSn)  and  dystrophic  mdx  (C57BL/MDX)  mice  (Jackson 
Laboratories,  Bar  Harbor,  ME) according  to  published  procedures  (Franco 
and  Lansman, 1990;  DiMario  and  Strohinan,  1988)  with  modifications.  12 
preparations  using  three  to  five  mice  of  each  kind  were  used  in  this  study. 
Myoblasts  were  obtained  from  freshly  isolated  hindlimb  muscles  of  2-8-wk 
old mice. We have detected no difference in the properties of myotubes pre- 
pared from mice of various ages. The muscles were minced to a fine con- 
sistency and incubated in a proteolytic enzyme solution containing 0.25% 
Collagenase B (Boehringer Mannheim Biochemicals,  Indianapolis,  IN) and 
0.1% Trypsin (Sigma Chemical Co., St. Louis, MO) in Hank's Ca- and Mg- 
free saline (Washington University Medical School Tissue Culture Support 
Center, St. Louis, Me) for 30 rain at 37°C. After digestion and proteolytic 
enzyme inhibition the tissue was pelleted by low speed centrifugetion.  The 
pellet was  rcsnspended in Ham's  F-10 medium (Washington  University 
Medical School Tissue Culture Support Center) and triturated several times 
to release satellite  ceils.  After low speed centrifugetion, the muscle cells 
were resuspended in proliferation medium consisting  of Ham's F-10 medium 
supplemented with 20% fetal bovine serum (Hyclone  Labs., Logan, UT) 
and 5% fetal equine serum (Sigma Chemical Co.). The cells were filtered 
through a  125-t~m pore size nylon mesh (Nytex; Tetko,  Inc.,  Monterey 
Park, CA) and prcplated for I-2 h to remove most fibroblasts. Next the cells 
were plated on dishes coated with 0.1% collagen and allowed to proliferate 
for 4-5 d. The cells were then mildly trypsinized (0.02% trypsin for 3 rain) 
to promote myoblast detachment, washed and plated on collagen  coated 
(0.1%) round (diam =  18 mm) glass coverslips at a density of about 25,000 
myohlasts per coverslip in proliferation medium. The next day the cells were 
switched to differentiation medium consisting of Ham's F-10 medium with 
20%  CPSR2  (Controlled Process  Serum Replacement-Type 2;  Sigma 
Chemical Co.),  1-3%  fetal  equine serum and  1%  glutamine.  3 d  later 
Ara-C (cytosine  ~-D-arabinofuranoside;  10 #g/ml; Sigma Chemical Co.) 
was added for 24 h to suppress fibroblast growth.  Myoblasts started to fuse 
within  2-3 d in  differentiation  medium  and  cell  deformation  measurements 
were  performed on myotubes incubated  in  this  medium for  5-9 d. 
Measurement  of  the  Stiffness 
of  the Membrane Skeleton 
Local cellular stiffness was measured as described for lymphocytes  (Paster- 
nak and Elson, 1985). This stiffness is a measure of the viscoelastic  resis- 
tance of the cell to indentation. Myotubes were grown and differentiated at- 
tached to collagen-coated  glass coverslips and then were immersed in a 12 
ml thermostated  chamber mounted on the microscope  stage. Measurements 
were made at 37°C  in MEM Earrs medium buffered with 20 mM Hepes 
(Washington  University  Medical School  Tissue  Cuimm Support  Center). 
The  surfaces  of  myombes  8-20  ~m in  diameter,  and  150-250-/~m  long  were 
slightly  indented  to  a  depth  of  0.7-0.9  #m by  a  glass  stylus  1  #m in  radius 
which  moved  according  to  a  triangular  waveform  with  an  amplitude  of  1.3 
~m and  a  speed  of  2.6  ~rrds.  The  stylus  was  mounted  on  a  glass  beam  with 
a  spring  constant  of  2.3  mdyne/gm. The  empirical  stiffness  parameter  was 
defined  as  the  resistance  per  unit  indentation  depth,  in  units  of  mdyne/~m. 
The  ingoing  curves  arc  linear  (Fig.  2),  and  so  the  stiffness  parameter  is  well 
defined. 
Immunofluorescence 
Procedures  for  fixation  and  labeling  of  myotubes on  glass  coverslips  were 
adapted  from  earlier  work (Miller  et  al.,  1985).  Briefly,  myotubes grown 
on collagen-coated  glass coverslips were fixed for 5 rain in 100% ethanol 
at room temperature,  washed with PBS and blocked with 2% BSA and 2% 
horse serum in PBS at 37°C for 1 h. A monoclonal antibody against adult 
skeletal  myosin heavy chain, F59 (a gift from Frank Stockdale,  Stanford 
University, Stanford,  CA), was added in blocking solution for 1 h at 37°C. 
The coverslip  was  then rinsed and incubated with a  rhodamine-labeled 
afffinity-purified goat anti-mouse IgG antibody (Orgenon-Teknika-Cappel, 
Malvern, PA). The coverslips  were rinsed and mounted in 90% glycerol 
containing 0.1 M n-propyl gellate  (Sigma Chemical Co.) to prevent pho- 
tobleaching.  The procedure for immunolabeling of dystrophin was similar 
except that a monoclunal antibody against dystrophin, DYS1 (Novocastra, 
Newcastle  upon Tyne, England)  was used. 
Figure 1. Images of  normal and mdx myotubes during measurement of  local  deformability.  At the cell  surface the dark spot at  the apex 
of  a shadowy triangle  is  the  tip  used to indent slightly  the surface  and the subsarcolcmrnal  cytoskelcton of  the cell.  (Top)  Myotube from 
a normal mouse. The stiffness  of  the  membrane skeleton was measured at  three  different  locations  along  the myotube. (Bottom) Myotubc 
from an mdx mouse measured at  three locations.  Bars: (top)  19 #m; (bottom) 26 #m. 
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Figure 2.  Examples of data 
obtained from the mechanical 
measurements. Each example 
was  chosen to represent the 
average stiffness value for its 
population. The slope of the 
ingoing curve (upper branch) 
indicates  the  stiffness  in 
rndyne/#m.  (Le~) Normal 
myotube, stiffness 1.25 mdyne/ 
#m.  (Right) mdx  myotube, 
stiffness 0.27 mdyne//~m. 
Results 
Normal Myotubes Are SUffer Than Those 
Which Lack, Dystrophin 
The local stiffness of the membrane skeleton was measured 
using a glass probe small enough (1/~m in radius) to measure 
several regions of the same myotube. Fig.  1 depicts cultured 
myotubes in the presence of the probe during measurement. 
On average, normal myotubes are almost fourfold stiffer than 
mdx myotubes. Measuring more than 50 cells of each type 
yields average stiffness values 1.23 +  0.04 mdyne/#m (mean 
+  SEM) for normal (113 measurements) and 0.34  +  0.014 
mdyne/#m for mdx myotubes (124 measurements).  Fig.  2 
depicts examples of deformability measurements selected to 
have stiffness values near the means for the two kinds ofmy- 
otubes.  Their differences can be  clearly  seen  even  in  a 
qualitative comparison of typical individual measurements. 
Measurements on a large number of cells show considerable 
variability in the stiffness values (Fig. 3). Nevertheless, the 
distributions  of the values for the two kinds of myotubes 
barely overlap. Hence, these measurements provide a sensi- 
tive indicator of dystrophin function in living muscle cells. 
We have verified the developmental stage of the myotubes 
using a monoclonal antibody to detect the expression of  adult 
sarcomeric muscle  myosin.  Irnmunofluorescence micros- 
copy shows that the myotubes cultured from normal and mdx 
mice express similar amounts of this form of myosin after 
5-8 d in differentiation medium (Fig. 4). Moreover, a mono- 
clonal antibody directed against the rod domain of dystro- 
phin detected this molecule uniformly distributed along nor- 
mal myotubes at this stage, but none was detected in the mdx 
myotubes under comparable conditions (Fig. 5). Normal and 
mdx myotubes have similar  morphologies and  in neither 
does the myosin have a sarcomeric pattern at this stage. 
We have also measured the stiffness of mononuclear myo- 
blasts from normal and mdx mice prior to expression of  dys- 
trophin. We observed that myoblasts are much softer than 
myotubes and that cells obtained from both normal (0.18 + 
0.08 mdyne//~m; 21 measurements) and mdx mice (0.18  + 
0.10 mdyne/#m; 22 measurements) yield the same relatively 
low stiffness values. Hence there is no detectable mechanical 
difference between  myoblasts  from normal  or dystrophic 
animals prior to differentiation into myotubes. 
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Figure 3.  Histogram of local 
cell stiffness values measured 
on normal and mdx myotubes. 
The overlap is very limited. 
The average values are:  nor- 
mal,  1.23  +  0.04  (SEM) 
mdyne/#m,  113  measure- 
merits,  (51 myotubes);  and 
mdx,  0.34  +  0.014 (SEM) 
mdyne//zm,  124  measure- 
ments,  (54  myotubes). The 
standard error of  the mean rep- 
resents  the  precision  of the 
measurement. 
Pasternak  et  al,  Mechanical Function of Dystrophin in Muscle Cells  357 Figure 4. Expression of  an adult isoform of muscle myosin in differentiated  mouse myotubes  detected by inununofluorescence. (Top) Normal 
myotube. (Left) Phase image. (Right) Immunofluorescence of labeled skeletal myosin, (Bottom) mdx myotube. (Left) Phase image. (Right) 
Immunofluorescence. Both types of myotubes have been in differentiating medium for 5 d before fixation and labeling. They express com- 
parable amounts of the adult isoform of muscle myosin which indicates that they are in a similar stage of differentiation. Sarcomeres are 
not yet developed at this stage and only nascent myofibrils are detected. Bats: (top) 21 /zm; (bottom)  17 pro. 
Possible Effects of Ca  2+ and Proteolysis on Stiffness 
Taking account of the structural and functional properties of 
dystrophin and its cellular location, it seems simplest to in- 
terpret our observations in terms of a contribution of dystro- 
phin to the mechanics of  the muscle cell membrane skeleton. 
Other interpretations could be suggested, however. For ex- 
ample, myotubes lacking dystrophin have an abnormal entry 
mechanism for (Franco and Lansman,  1990) and elevated 
concentrations of (Turner et al., 1991) calcium ions. Exces- 
sive  calcium  ion  concentration  might  activate  proteases 
(Turner et al.,  1988) which could weaken the cytoskeletal 
matrix. We have tested the possibility that the lower stiffness 
of mdx myotubes was due to abnormally elevated intracellu- 
lax concentrations of calcium ions (Turner et al.,  1991) by 
incubating mdx myotubes in medium containing  1/10 the 
physiological concentration of Ca  2÷, 0.18 raM, for 3 d. This 
external  Ca  2+  concentration  lowers  the  cytoplasmic  Ca  2÷ 
concentration in mdx fibers to values close to those observed 
in  normal  fibers  (Turner  et  al.,  1988). We  detected  no 
significant effect on the stiffness of mdx myotubes: stiffness 
=  0.3  ±  0.09 mdyne//~m (36 measurements) versus 0.34 
mdyne//~m for myotubes in standard medium containing 1.8 
mM Ca  2+.  Cytoplasmic Ca  2+ concentration is more tightly 
regulated in  normal mouse myotubes and therefore more 
difficult to modulate (Fong et al., 1990). We tested the effect 
of elevated extracellular Ca  ~+ on normal myotubes by in- 
cubating them for 1.5 h in medium containing 9.0 mM Ca  2÷ 
and for further 40 rain in  18 mM Ca  2+ at 37°C. After this 
treatment their stiffness decreased slightly from 1.0 ±  0.02 
mdyne//zm (17 measurements) to 0.9 ±  0.018 mdyne//~m (16 
measurements). To test whether proteolysis due to a higher 
cytoplasmic Ca  2+ concentration influences the stiffness, we 
incubated  mdx  myotubes for 4  d  with  50  #M  leupeptin 
(Sigma Chemical Co.) (Turner et al., 1993) and found no in- 
The Journal  of  Cell  Biology, Volume  128,  1995  358 Figure 5. Expression of dystrophin in differentiated mouse myotubes detected by immunofluorescence. (/bp) Normal myotube showing 
a diffuse distribution of dystrophin. (Left) Phase image. (Right) Immunofluorescence detection of dystrophin. (Bottom) mdx myotube; no 
dystrophin is detected.  (Left) Phase image. (Right) Immunofluorescence. Bars: (top) 21/~m;  (bottom)  17 t~m. 
crease  of stiffness  (0.31  :t:  0.02  mdyne/t~m;  27  measure- 
ments). Therefore, we conclude that dystrophin has a direct 
effect on the stiffness of muscle cells. The observed changes 
in calcium ion permeability in dystrophic muscle cells could 
be caused by effects of dystrophin  deficiency in the mem- 
brane  skeleton  on  the  function  of calcium  ion  channels 
(Lansman and Franco,  1991). 
Discussion 
The  structure  of dystrophin  suggests a  number of interac- 
tions which could be important for cell mechanics.  Similar 
to anloyrin in erythrocytes it could link specific plasma mem- 
brane proteins (Ervasti et al.,  1990) to an underlying visco- 
elastic filament matrix  via its actin-binding  domain (Hem- 
mings et al.,  1992). Having a domain analogous to spectrin, 
dystrophin  also  might  contribute  to  membrane  elasticity 
(Watkins et al.,  1988) by acting as a molecular spring (Elg- 
saeter  et  al.,  1986).  (The  shear  elasticity  of erythrocyte 
membranes is proportional to the surface density of spectrin; 
Waugh and Agre,  1988).  Finally, dystrophin is linked to a 
complex of associated  glycoproteins  (DAGs)  (Ervasti  and 
Campbell,  1993a) one of which,  156K DAG (ol-dystrogly- 
can), binds laminin (Ervasti and Campbell,  1993c) and has 
also  recently  been  shown  to be an  agrin  receptor  (Cam- 
panelli et al.,  1994; Gee et al.,  1994). In myotubes dystro- 
phin is colocalized with laminin in the extraceLlular  matrix 
(Dickson et al.,  1992).  Hence,  the complex of dystrophin 
and DAGs could link the cell membrane to the extraceUular 
matrix and so function similarly to integrins  or cadherins. 
Nevertheless,  a,-dystroglycan is not related to other known 
laminin binding proteins nor to integrins or cadherins (lbrag- 
himov-Beskrovnaya, 1992), and important organizational dif- 
ferences between the dystrophin system and integrins and cad- 
herins have been seen in smooth muscle (North et al., 1993). 
By acting as a molecular spring  or as a link both to the 
actin  cytoskeleton and the extracellular  matrix  dystrophin 
could  redistribute  stresses  imposed  locally  on  the  sar- 
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ing  dystrophin unrelieved  localized  stresses  could  more 
readily disrupt the sarcolemma, activate intracellular degra- 
dation, and thereby kill the cell (Mokri and Engel,  1975; 
Weller et al.,  1990;  Moens et al.,  1993). 
If any of  the links in the chain of interactions from the actin 
cytoskeleton through dystrophin and the DAGs to the ex- 
tracellular matrix is missing, the function of the entire chain 
could be disrupted. Expression of  the DAGs is much reduced 
in the absence of dystrophin (Ohlendieck and Campbell, 
1991). Their absence and the consequent loss of the linkage 
to the extracellular matrix could also contribute to mem- 
brane instability. Indeed, the absence of a single DAG in the 
presence of dystrophin causes symptoms of muscular dys- 
trophy (Matsumura et al., 1992; Matsumura and Campbell, 
1994). 
In contrast to the large difference in deformability between 
normal and mdx myotubes which we have seen, little or no 
difference was observed in the pressure required to rupture 
the cell membrane in a micropipette (Franco and Lansman, 
1990; Hutter et al., 1991). These micropipette experiments 
measure resistance to membrane area stretching (Hutter et 
al., 1991). Due to the surplus of surface membrane on mus- 
cle  cells  (Dulhunty  and  Franzini-Armstrong,  1975),  the 
small indentations in our measurements should not stretch 
the membrane significantly. In analogy with erythrocytes 
(Steck, 1989), the stiffness which we have measured should 
result mainly from resistance to shear deformations of the 
membrane cytoskeletal cortex. Therefore the chain of inter- 
actions to which dystrophin contributes apparently strongly 
influences the shear but not the area stretching modulus of 
the sarcolemma. In erythrocytes the stretching modulus de- 
pends substantially on both the membrane lipid bilayer and 
the spectrin-actin matrix of the membrane skeleton (Evans 
et al.,  1976). 
Relative to normal muscle cells, myotubes and muscle 
fibers  from  mdx  mice  show  increased  osmotic  fragility 
(Menke and Jockusch,  1991). Osmotic shock of myofibers 
causes the formation of membrane blebs which lead to rup- 
ture of the membrane,  hypercontraction of the cell,  and 
death. Measurements of osmotic fragility, however, due to 
their irreversibility and the possible effects of changes in cy- 
toplasmic  osmolality on the  organization of cytoskeletal 
structures are more difficult to interpret in simple mechani- 
cal terms than are relatively nonperturbing measurements of 
the local stiffness of the membrane skeleton. It has been pro- 
posed that these cells rupture more readily because they have 
less  excess membrane than analogous cells from normal 
mice (Hutter et al.,  1991). 
Measurements of local cellular deformability can provide 
important information about the relationship between the 
structure of dystrophin and its cellular mechanical function. 
For example, the relative contributions of the spring and 
linkage functions of dystrophin might be learned from mea- 
surements of the deformability of myotubes or muscle fibers 
containing shortened dystrophin molecules produced by mo- 
lecular genetic techniques or such as occur in patients with 
Becker muscular dystrophies (England et al., 1990). In addi- 
tion, these measurements also could provide a direct quan- 
titative measure of the function of dystrophin in intact living 
muscle cells prior to the appearance of membrane damage 
and its ensuing consequences. This would be especially use- 
ful to characterize reconstitution of dystrophin into cells 
originally lacking this protein (Morgan et al., 1990; Acsadi 
et al.,  1991; Cox et al.,  1993).  The difference in stiffness 
values between normal and mdx myotubes compared with 
their precision suggests that these measurements should pro- 
vide a sensitive test of whether reconstituted dystrophin is 
functioning normally to stabilize the sarcolemma. Recent 
measurements on mdx myotubes to which dystrophin has 
been restored have verified this expectation by demonstrat- 
ing a concurrent restoration of stiffness (manuscript in prep- 
aration). 
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